FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

116087001: Cilostazol (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
177258015 Cilostazol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
674808016 Cilostazol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
177258015 Cilostazol en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
177258015 Cilostazol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
674808016 Cilostazol (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
674808016 Cilostazol (substance) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT core
674808016 Cilostazol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
366041000195116 cilostazolo it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
1117971000241115 cilostazol fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
1117971000241115 cilostazol fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
366041000195116 cilostazolo it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cilostazol Is a Médicament antiagrégant plaquettaire false Inferred relationship Existential restriction modifier (core metadata concept)
Cilostazol Is a agent antiplaquettaire false Inferred relationship Existential restriction modifier (core metadata concept)
Cilostazol Is a Phosphodiesterase inhibitor false Inferred relationship Existential restriction modifier (core metadata concept)
Cilostazol Has disposition Phosphodiesterase inhibitor (disposition) false Inferred relationship Existential restriction modifier (core metadata concept)
Cilostazol Is a produit chimique catégorisé selon sa fonction false Inferred relationship Existential restriction modifier (core metadata concept)
Cilostazol Is a Enzyme inhibitor false Inferred relationship Existential restriction modifier (core metadata concept)
Cilostazol Is a Amide true Inferred relationship Existential restriction modifier (core metadata concept)
Cilostazol Is a Tetrazole (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Cilostazol Has disposition Platelet aggregation inhibitor (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Cilostazol Is a Platelet aggregation inhibitor true Inferred relationship Existential restriction modifier (core metadata concept)
Cilostazol Is a Vasodilator (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Cilostazol Is a Substance with phosphodiesterase 3 inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Cilostazol Has disposition Phosphodiesterase 3 inhibitor (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Cilostazol 100 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cilostazol Inferred relationship Existential restriction modifier (core metadata concept)
Cilostazol 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cilostazol Inferred relationship Existential restriction modifier (core metadata concept)
Product containing cilostazol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cilostazol Inferred relationship Existential restriction modifier (core metadata concept) 1
Cilostazol 100 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cilostazol Inferred relationship Existential restriction modifier (core metadata concept) 1
Cilostazol 100 mg oral tablet Has basis of strength substance (attribute) True Cilostazol Inferred relationship Existential restriction modifier (core metadata concept) 1
Cilostazol 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cilostazol Inferred relationship Existential restriction modifier (core metadata concept) 1
Cilostazol 50 mg oral tablet Has basis of strength substance (attribute) True Cilostazol Inferred relationship Existential restriction modifier (core metadata concept) 1
Cilostazol 100 mg oral tablet Has precise active ingredient True Cilostazol Inferred relationship Existential restriction modifier (core metadata concept) 1
Cilostazol 50 mg oral tablet Has precise active ingredient True Cilostazol Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing cilostazol in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cilostazol Inferred relationship Existential restriction modifier (core metadata concept) 1
Cilostazol only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cilostazol Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only cilostazol in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cilostazol Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start